M
Matthew J. McQueen
Researcher at McMaster University
Publications - 210
Citations - 35087
Matthew J. McQueen is an academic researcher from McMaster University. The author has contributed to research in topics: Population & Myocardial infarction. The author has an hindex of 59, co-authored 206 publications receiving 31280 citations. Previous affiliations of Matthew J. McQueen include Glasgow Royal Infirmary & Libin Cardiovascular Institute of Alberta.
Papers
More filters
Journal ArticleDOI
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Salim Yusuf,Steven Hawken,Stephanie Ôunpuu,Tony Dans,Alvaro Avezum,Fernando Lanas,Matthew J. McQueen,Andrzej Budaj,Prem Pais,John Varigos,Liu Lisheng +10 more
TL;DR: Abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits, vegetables, and alcohol, and regular physical activity account for most of the risk of myocardial infarction worldwide in both sexes and at all ages in all regions.
Journal ArticleDOI
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin O'Donnell,Martin O'Donnell,Denis Xavier,Lisheng Liu,Hongye Zhang,Siu Lim Chin,Purnima Rao-Melacini,Sumathy Rangarajan,Shofiqul Islam,Prem Pais,Matthew J. McQueen,Charles Mondo,Albertino Damasceno,Patricio Lopez-Jaramillo,Graeme J. Hankey,Antonio L. Dans,Khalid Yusoff,Thomas Truelsen,Hans-Christoph Diener,Ralph L. Sacco,Danuta Ryglewicz,Anna Członkowska,Christian Weimar,Xingyu Wang,Salim Yusuf +24 more
TL;DR: The findings suggest that ten risk factors are associated with 90% of the risk of stroke, and targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.
Journal ArticleDOI
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Eva Lonn,Salim Yusuf,J.M. Arnold,Janice Pogue,Mary Micks,Matthew J. McQueen,Jeffrey L. Probstfield +6 more
TL;DR: Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease.
Journal ArticleDOI
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
Johannes F.E. Mann,Roland E. Schmieder,Matthew J. McQueen,Leanne Dyal,Helmut Schumacher,Janice Pogue,Xingyu Wang,Aldo P. Maggioni,Andrzej Budaj,Suphachai Chaithiraphan,Kenneth Dickstein,Matyas Keltai,Kaj Metsärinne,Ali Oto,Alexander Parkhomenko,Leopoldo S. Piegas,Tage Lysbo Svendsen,Koon K. Teo,Salim Yusuf +18 more
TL;DR: In people at high vascular risk, telmisartan's effects on major renal outcomes are similar to ramipril, and although combination therapy reduces proteinuria to a greater extent than monotherapy, overall it worsens major renal outcome.
Journal Article
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary
Pantelis Sarafidis,George L. Bakris,Johannes F.E. Mann,Roland E. Schmieder,Matthew J. McQueen,Leanne Dyal,Helmut Schumacher,Janice Pogue,Xingyu Wang,Aldo P. Maggioni,Andrzej Budaj,Suphachai Chaithiraphan,Kenneth Dickstein,Matyas Keltai,Kaj Metsärinne,All Oto,Alexander Parkhomenko,Leopoldo S. Piegas,Tage Lysbo Svendsen,Koon K. Teo,Salim Yusuf +20 more
TL;DR: In this article, the authors investigated the renal effects of Ramipril (an ACE inhibitor), telmisartan (an ARB), and their combination in patients aged 55 years or older with established atherosclerotic vascular disease or with diabetes with end-organ damage.